

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Frid...


Clinigen and Humanigen partner to progress investigational Covid drug


TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"


(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distrib...


(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.


Clinigen shares fall on lowered outlook as profit more than doubles


AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls


LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold